3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
24
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Fallopian Tube Neoplasms
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Sleep Wake Disorders
1
Ovarian Neoplasms
1
Malignant Solid Neoplasm
1
Lung Neoplasms
1
Fatigue
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma in Situ
1
Brenner Tumor
1
Anxiety Disorders
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
Fluorouracil
29
Leucovorin
26
Oxaliplatin
25
Capecitabine
16
Irinotecan
14
Cetuximab
10
Bevacizumab
9
Radiotherapy
8
Panitumumab
5
Folfox protocol
5
Surgical Procedures, Operative
3
Levamisole
3
Celecoxib
3
tremelimumab
2
neratinib
2
napabucasin
2
durvalumab
2
cediranib
2
aflibercept
2
X-Rays
2
Tegafur
2
Radiofrequency Ablation
2
Psychiatric Rehabilitation
2
Preoperative Exercise
2
Octreotide
2
Mitomycin
2
Interviews as Topic
2
Immunoglobulin G
2
Folic Acid
2
Floxuridine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Colorectal Neoplasms
×
Early Intervention, Educational
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts